SPOTLIGHT -
April 11th 2024
Is it possible to win in Asia’s private market?
February 8th 2024
The three key themes likely to shape pharma fortunes in 2024.
January 19th 2024
A growing number of domestic drug developers are setting their sights on overseas markets.
November 16th 2023
An overview of what biopharma C-Suites and their boards should consider when engaging with government and business leaders from China, the world’s second largest economy.
November 3rd 2023
Raja discusses how the pharma industry can improve its ecological impact.
New Insights Into Open Innovation
Open innovation is sometimes chaotic and often difficult to measure, but getting it right can give firms a real edge now and in the future.
Mentoring the Mavericks
Having a 'maverick' in your company can lead to problems as well as breakthroughs and innovations. Judith Germain outlines the value of harnessing a brilliant but wayward talent.
Report Predicts Major Slowdown for Big Pharma
4 March, 2010
The New Merck's Move on Emerging Markets
Can the combination with Schering-Plough transform the company from an also-ran to a contender in the big push for market share in the developing world?
Advancing Drug Discovery With Research Informatics
Anirban Ghosh and Siddharth Sawhney explain how research informatics tools can advance the speed and success of drug discovery research.
The Power of Successful Negotiation
A corporate focus on negotiation can help organizations reap substantial and measurable benefit, writes Alison Morris.
Positive Outlook for UK Biotech Jobs
February 26, 2010.
Genzyme Expands UK Site
February 18, 2010.
The Seven Deadly Sins of Marketing Excellence
Marketing excellence programmes are popular, important and frequently flawed, says Dr Brian D. Smith
Former Schering-Plough CEO Speaks Out on M&As
February 16, 2010.
Europe Reveals Generic Dominance
February 10, 2010.
Actavis Ray of Hope for Beleaguered Iceland
8 February, 2010.
EU Pricing Dilemmas
Although representing a huge market, the EU also presents problems that hamper profitability- particularly when it comes to differing price regulations across member states.
Emergency Contraception Drug Breakthrough
January 29, 2010.
EC to Scrutinize Patent Settlements
January 13, 2010.
Recruiting and Retaining R&D Staff in a Recession
Dr Kay Wardle of RSA examines the impact of short-term survival strategies on pre-clinical R&D organizations.
GSKs Andrew Witty New EFPIA President
January 06, 2010.
Novartis Eyes Full Takeover of Alcon
January 04. 2010.
Pharma's New Commercialization Model
Quintiles' Jim Featherstone asks what the end of the blockbuster generation means for the sales operation?s business model and how pharma should react to the transition.
Branding the Pharma Merger
David Sun of InterbrandHealth looks at global pharma branding trends for 2010 and beyond.
Lobbyists Use Limp Sandwiches to Shape the Pharmaceutical Package
Reflector reports on how the European pharma commitees and national associations are trying to shape the upcoming pharmaceutical package through informal
UK Pharmacies Dealing with Drug Shortages
With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?
Guiding Your Drug Name to Approval
06 August 2009
Obama Advisor to Open Swedish Life Sciences Summit
18 August 2009
Is Tamiflu Suitable for Young Children?
11 August
Pfizer settles Nigerian Trovan case
3 August 2009
A busy time for Sanofi
31 July 2009
Statins Get Boost from New Study
Statins should be given to people with high blood pressure or diabetes, even if they don?t have heart disease, according to a study published in the British Medical Journal.
UK 'Life Sciences Blueprint' Welcomed
16 July 2009
Servier Singled Out for New EU Antitrust Investigation
08 July 2009